APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hay Fever and Allergic Rhinitis Decongestants Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Hay Fever and Allergic Rhinitis Decongestants Drug Market Outlook and Growth Opportunities 2026

22 December 2025195 pages

Choose your research edition.

Industry ResearchHay Fever and Allergic Rhinitis Decongestants Drug Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Hay Fever and Allergic Rhinitis Decongestants Drug Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Hay Fever and Allergic Rhinitis Decongestants Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hay Fever and Allergic Rhinitis Decongestants Drug Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Hay Fever and Allergic Rhinitis Decongestants Drug Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Hay Fever and Allergic Rhinitis Decongestants Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Hay Fever and Allergic Rhinitis Decongestants Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hay Fever and Allergic Rhinitis Decongestants Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hay Fever and Allergic Rhinitis Decongestants Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Hay Fever and Allergic Rhinitis Decongestants Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Hay Fever and Allergic Rhinitis Decongestants Drug market include Shenzhen Daphne, Johnson & Johnson, Nanjing Tianlang, Nanjing Haijing, Mingsheng Pharma, Dandong Pharma, Procter & Gamble, Bayer and Foundation Consumer Brands, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Hay Fever and Allergic Rhinitis Decongestants Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hay Fever and Allergic Rhinitis Decongestants Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hay Fever and Allergic Rhinitis Decongestants Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hay Fever and Allergic Rhinitis Decongestants Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Hay Fever and Allergic Rhinitis Decongestants Drug Segment by Company

Shenzhen Daphne

Johnson & Johnson

Nanjing Tianlang

Nanjing Haijing

Mingsheng Pharma

Dandong Pharma

Procter & Gamble

Bayer

Foundation Consumer Brands

B.F. Ascher & Company

Hay Fever and Allergic Rhinitis Decongestants Drug Segment by Type

Nasal Spray

Tablet

Hay Fever and Allergic Rhinitis Decongestants Drug Segment by Application

Clinic

Hospital

Pharmacy Retail

Other

Hay Fever and Allergic Rhinitis Decongestants Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Hay Fever and Allergic Rhinitis Decongestants Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Hay Fever and Allergic Rhinitis Decongestants Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Hay Fever and Allergic Rhinitis Decongestants Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Hay Fever and Allergic Rhinitis Decongestants Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hay Fever and Allergic Rhinitis Decongestants Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hay Fever and Allergic Rhinitis Decongestants Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hay Fever and Allergic Rhinitis Decongestants Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hay Fever and Allergic Rhinitis Decongestants Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hay Fever and Allergic Rhinitis Decongestants Drug industry.

Chapter 3: Detailed analysis of Hay Fever and Allergic Rhinitis Decongestants Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Hay Fever and Allergic Rhinitis Decongestants Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Hay Fever and Allergic Rhinitis Decongestants Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Hay Fever and Allergic Rhinitis Decongestants Drug Industry Trends Table 2. Hay Fever and Allergic Rhinitis Decongestants Drug Industry Drivers Table 3. Hay Fever and Allergic Rhinitis Decongestants Drug Industry Opportunities and Challenges Table 4. Hay Fever and Allergic Rhinitis Decongestants Drug Industry Restraints Table 5. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Share by Company (2021-2026) Table 7. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Volume by Company (k units) & (2021-2026) Table 8. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Volume Share by Company (2021-2026) Table 9. Global Hay Fever and Allergic Rhinitis Decongestants Drug Average Price (US$/unit) of Company (2021-2026) Table 10. Global Hay Fever and Allergic Rhinitis Decongestants Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Hay Fever and Allergic Rhinitis Decongestants Drug Key Company Manufacturing Base & Headquarters Table 12. Global Hay Fever and Allergic Rhinitis Decongestants Drug Company, Product Type & Application Table 13. Global Hay Fever and Allergic Rhinitis Decongestants Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Hay Fever and Allergic Rhinitis Decongestants Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Nasal Spray Table 18. Significant Companies of Tablet Table 19. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Volume by Type (2021-2026) & (k units) Table 21. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Volume by Type (2027-2032) & (k units) Table 22. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Volume Share by Type (2021-2026) Table 23. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Volume Share by Type (2027-2032) Table 24. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type (2021-2026) Table 28. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Clinic Table 30. Significant Companies of Hospital Table 31. Significant Companies of Pharmacy Retail Table 32. Significant Companies of Other Table 33. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Volume by Application (2021-2026) & (k units) Table 35. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Volume by Application (2027-2032) & (k units) Table 36. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Volume Share by Application (2021-2026) Table 37. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Volume Share by Application (2027-2032) Table 38. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application (2021-2026) Table 42. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application (2027-2032) Table 43. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Region (2021-2026) & (k units) Table 45. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Region (2021-2026) Table 46. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Region (2027-2032) & (k units) Table 47. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Region (2027-2032) Table 48. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Region (2021-2026) Table 51. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Region (2027-2032) Table 53. Global Hay Fever and Allergic Rhinitis Decongestants Drug Market Average Price (US$/unit) by Region (2021-2026) Table 54. Global Hay Fever and Allergic Rhinitis Decongestants Drug Market Average Price (US$/unit) by Region (2027-2032) Table 55. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2021-2026) & (k units) Table 58. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Country (2021-2026) Table 59. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2027-2032) & (k units) Table 60. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Country (2027-2032) Table 61. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Market Share by Country (2021-2026) Table 63. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Market Share by Country (2027-2032) Table 65. Shenzhen Daphne Company Information Table 66. Shenzhen Daphne Business Overview Table 67. Shenzhen Daphne Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Shenzhen Daphne Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 69. Shenzhen Daphne Recent Development Table 70. Johnson & Johnson Company Information Table 71. Johnson & Johnson Business Overview Table 72. Johnson & Johnson Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Johnson & Johnson Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 74. Johnson & Johnson Recent Development Table 75. Nanjing Tianlang Company Information Table 76. Nanjing Tianlang Business Overview Table 77. Nanjing Tianlang Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Nanjing Tianlang Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 79. Nanjing Tianlang Recent Development Table 80. Nanjing Haijing Company Information Table 81. Nanjing Haijing Business Overview Table 82. Nanjing Haijing Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Nanjing Haijing Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 84. Nanjing Haijing Recent Development Table 85. Mingsheng Pharma Company Information Table 86. Mingsheng Pharma Business Overview Table 87. Mingsheng Pharma Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Mingsheng Pharma Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 89. Mingsheng Pharma Recent Development Table 90. Dandong Pharma Company Information Table 91. Dandong Pharma Business Overview Table 92. Dandong Pharma Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Dandong Pharma Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 94. Dandong Pharma Recent Development Table 95. Procter & Gamble Company Information Table 96. Procter & Gamble Business Overview Table 97. Procter & Gamble Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Procter & Gamble Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 99. Procter & Gamble Recent Development Table 100. Bayer Company Information Table 101. Bayer Business Overview Table 102. Bayer Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Bayer Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 104. Bayer Recent Development Table 105. Foundation Consumer Brands Company Information Table 106. Foundation Consumer Brands Business Overview Table 107. Foundation Consumer Brands Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Foundation Consumer Brands Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 109. Foundation Consumer Brands Recent Development Table 110. B.F. Ascher & Company Company Information Table 111. B.F. Ascher & Company Business Overview Table 112. B.F. Ascher & Company Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. B.F. Ascher & Company Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 114. B.F. Ascher & Company Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Hay Fever and Allergic Rhinitis Decongestants Drug Distributors List Table 118. Hay Fever and Allergic Rhinitis Decongestants Drug Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Hay Fever and Allergic Rhinitis Decongestants Drug Product Image Figure 2. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales (2021-2032) & (k units) Figure 5. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Hay Fever and Allergic Rhinitis Decongestants Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Nasal Spray Image Figure 10. Tablet Image Figure 11. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Volume Share by Type (2021-2032) Figure 14. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type (2021-2032) Figure 17. Clinic Image Figure 18. Hospital Image Figure 19. Pharmacy Retail Image Figure 20. Other Image Figure 21. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Volume Share by Application (2021-2032) Figure 24. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application (2021-2032) Figure 27. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value (2021-2032) & (US$ Million) Figure 32. North America Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value (2021-2032) & (US$ Million) Figure 38. South America Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Hay Fever and Allergic Rhinitis Decongestants Drug Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Hay Fever and Allergic Rhinitis Decongestants Drug Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Nasal Spray
  • Tablet
Applications
  • Clinic
  • Hospital
  • Pharmacy Retail
  • Other
Companies covered
  • Shenzhen Daphne
  • Johnson & Johnson
  • Nanjing Tianlang
  • Nanjing Haijing
  • Mingsheng Pharma
  • Dandong Pharma
  • Procter & Gamble
  • Bayer
  • Foundation Consumer Brands
  • B.F. Ascher & Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value (2021-2032)
  4. 1.2.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Hay Fever and Allergic Rhinitis Decongestants Drug Market Dynamics
  1. 2.1 Hay Fever and Allergic Rhinitis Decongestants Drug Industry Trends
  2. 2.2 Hay Fever and Allergic Rhinitis Decongestants Drug Industry Drivers
  3. 2.3 Hay Fever and Allergic Rhinitis Decongestants Drug Industry Opportunities and Challenges
  4. 2.4 Hay Fever and Allergic Rhinitis Decongestants Drug Industry Restraints
3 Hay Fever and Allergic Rhinitis Decongestants Drug Market by Company
  1. 3.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Company Revenue Ranking in 2025
  2. 3.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Company (2021-2026)
  3. 3.3 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Hay Fever and Allergic Rhinitis Decongestants Drug Average Price by Company (2021-2026)
  5. 3.5 Global Hay Fever and Allergic Rhinitis Decongestants Drug Company Ranking (2024-2026)
  6. 3.6 Global Hay Fever and Allergic Rhinitis Decongestants Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Hay Fever and Allergic Rhinitis Decongestants Drug Company Product Type and Application
  8. 3.8 Global Hay Fever and Allergic Rhinitis Decongestants Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Hay Fever and Allergic Rhinitis Decongestants Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Hay Fever and Allergic Rhinitis Decongestants Drug Market by Type
  1. 4.1 Hay Fever and Allergic Rhinitis Decongestants Drug Type Introduction
  2. 4.1.1 Nasal Spray
  3. 4.1.2 Tablet
  4. 4.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Volume by Type
  5. 4.2.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value by Type
  9. 4.3.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value by Type (2021-2032)
  11. 4.3.3 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type (2021-2032)
5 Hay Fever and Allergic Rhinitis Decongestants Drug Market by Application
  1. 5.1 Hay Fever and Allergic Rhinitis Decongestants Drug Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Pharmacy Retail
  5. 5.1.4 Other
  6. 5.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Volume by Application
  7. 5.2.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value by Application
  11. 5.3.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value by Application (2021-2032)
  13. 5.3.3 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application (2021-2032)
6 Hay Fever and Allergic Rhinitis Decongestants Drug Regional Sales and Value Analysis
  1. 6.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Region (2027-2032)
  5. 6.3 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Hay Fever and Allergic Rhinitis Decongestants Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value (2021-2032)
  12. 6.6.2 North America Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value (2021-2032)
  21. 6.9.2 South America Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Country, 2025 VS 2032
7 Hay Fever and Allergic Rhinitis Decongestants Drug Country-level Sales and Value Analysis
  1. 7.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2027-2032)
  6. 7.4 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Hay Fever and Allergic Rhinitis Decongestants Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Shenzhen Daphne
  2. 8.1.1 Shenzhen Daphne Company Information
  3. 8.1.2 Shenzhen Daphne Business Overview
  4. 8.1.3 Shenzhen Daphne Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Shenzhen Daphne Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  6. 8.1.5 Shenzhen Daphne Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Nanjing Tianlang
  14. 8.3.1 Nanjing Tianlang Company Information
  15. 8.3.2 Nanjing Tianlang Business Overview
  16. 8.3.3 Nanjing Tianlang Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Nanjing Tianlang Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  18. 8.3.5 Nanjing Tianlang Recent Developments
  19. 8.4 Nanjing Haijing
  20. 8.4.1 Nanjing Haijing Company Information
  21. 8.4.2 Nanjing Haijing Business Overview
  22. 8.4.3 Nanjing Haijing Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Nanjing Haijing Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  24. 8.4.5 Nanjing Haijing Recent Developments
  25. 8.5 Mingsheng Pharma
  26. 8.5.1 Mingsheng Pharma Company Information
  27. 8.5.2 Mingsheng Pharma Business Overview
  28. 8.5.3 Mingsheng Pharma Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Mingsheng Pharma Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  30. 8.5.5 Mingsheng Pharma Recent Developments
  31. 8.6 Dandong Pharma
  32. 8.6.1 Dandong Pharma Company Information
  33. 8.6.2 Dandong Pharma Business Overview
  34. 8.6.3 Dandong Pharma Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Dandong Pharma Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  36. 8.6.5 Dandong Pharma Recent Developments
  37. 8.7 Procter & Gamble
  38. 8.7.1 Procter & Gamble Company Information
  39. 8.7.2 Procter & Gamble Business Overview
  40. 8.7.3 Procter & Gamble Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Procter & Gamble Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  42. 8.7.5 Procter & Gamble Recent Developments
  43. 8.8 Bayer
  44. 8.8.1 Bayer Company Information
  45. 8.8.2 Bayer Business Overview
  46. 8.8.3 Bayer Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Bayer Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  48. 8.8.5 Bayer Recent Developments
  49. 8.9 Foundation Consumer Brands
  50. 8.9.1 Foundation Consumer Brands Company Information
  51. 8.9.2 Foundation Consumer Brands Business Overview
  52. 8.9.3 Foundation Consumer Brands Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Foundation Consumer Brands Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  54. 8.9.5 Foundation Consumer Brands Recent Developments
  55. 8.10 B.F. Ascher & Company
  56. 8.10.1 B.F. Ascher & Company Company Information
  57. 8.10.2 B.F. Ascher & Company Business Overview
  58. 8.10.3 B.F. Ascher & Company Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 B.F. Ascher & Company Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  60. 8.10.5 B.F. Ascher & Company Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hay Fever and Allergic Rhinitis Decongestants Drug Value Chain Analysis
  2. 9.1.1 Hay Fever and Allergic Rhinitis Decongestants Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hay Fever and Allergic Rhinitis Decongestants Drug Sales Mode & Process
  6. 9.2 Hay Fever and Allergic Rhinitis Decongestants Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hay Fever and Allergic Rhinitis Decongestants Drug Distributors
  9. 9.2.3 Hay Fever and Allergic Rhinitis Decongestants Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst